カレントテラピー　31-6　サンプル page 9/32

このページは カレントテラピー　31-6　サンプル の電子ブックに掲載されている9ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要：
カレントテラピー　31-6　サンプル

12 Current Therapy 2013 Vol.31 No.6570box is essential for tissue specific erythropoietin geneexpression. Blood 111：5223-5232, 20087）Le Douarin NM, Teillet MA：Experimental analysis of themigration and differentiation of neuroblasts of the autonomicnervous system and of neurectodermal mesenchymal derivatives,using a biological cell marking technique. Dev Biol 41：162-184, 19748）Yamauchi Y, Abe K, Mantani A, et al：A novel transgenictechnique that allows specific marking of the neural crestcell lineage in mice. Dev Biol 212（1）：191-203, 19999）Asada N, Takase M, Nakamura J, et al：Dysfunction of fibroblastsof extrarenal origin underlies renal fibrosis and renalanemia in mice. J Clin Invest 121：3981-3990, 201110）Melamed ML, Blackwell T, Neugarten J, et al：Raloxifen, aselective estrogen receptor modulator, is renoprotective：apost-hoc analysis. Kidney Int 79：241-249, 201111）Grgic I, Campanholle G, Bijol V, et al：Targeted proximaltubule injury triggers interstitial fibrosis and glomerulosclerosis.Kidney Int 82：172-183, 201212）Yang L, Besschetnova TY, Brooks CR, et al：Epithelial cellcycle arrest in G2/M mediates kidney fibrosis after injury.Nat Med 16：535-543, 201013）Bechtel W, McGoohan S, Zeisberg EM, et al：Methylationdetermines fibroblast activation and fibrogenesis in the kidney.Nat Med 16：544-550, 201014）Yanagita M：Inhibitors/antagonists of the TGF-β systemin kidney fibrosis. Nephrol Dial Transplant 27：3686-3691,201215）Zeisberg M, Hanai J, Sugimoto H, et al：BMP-7 counteractsTGF -beta1-induced epithelial -to -mesenchymal transitionand reverses chronic renal injury. Nat Med 9：964-968, 200316）Yanagita M, Oka M, Watabe T, et al：USAG-1：a bone morphogeneticprotein antagonist abundantly expressed in thekidney. Biochem Biophys Res Commun 316：490-500, 200417）Yanagita M, Okuda T, Endo S, et al：Uterine sensitizationassociatedgene -1（USAG -1）, a novel BMP antagonistexpressed in the kidney, accelerates tubular injury. J ClinInvest 116：70-79, 200618）Tanaka M, Asada M, Higashi AY, et al：Loss of the BMPantagonist USAG-1 ameriolates disease in a mouse model ofthe progressive hereditary kidney disease Alport syndrome.J Clin Invest 120：768-777, 2010